Focus Feature: COVID-related hospitalizations are rare after Paxlovid treatment
Less than 1% of patients who received Paxlovid ended up in the hospital or emergency department for COVID-19 in the 5 to 15 days following treatment.
R&E News and Features
Down syndrome linked to higher risk of severe COVID-19
People with Down syndrome who are infected with COVID-19 face higher risk of hospitalization and death than those without the condition.
New approach reduces colon cancer deaths
A comprehensive approach to improving colon cancer care at Kaiser Permanente in Southern California resulted in a 24% decrease in mortality over 7 years.
Omicron variant infections less severe than delta
When both the delta and omicron variants were circulating, patients who had SARS-CoV-2 infections with the omicron variant had substantially less risk of severe illness and shorter hospital stays than those infected with delta.
Dr. Anny Xiang honored with prestigious award
Dr. Anny Xiang, the scientific director of our Division of Biostatics Research, received the American Diabetes Association’s 2022 Norbert Freinkel Award, ADA’s highest award for outstanding contributions in the field of diabetes and pregnancy.
In the News
Vaccines for young children are coming but many parents have tough questions
The New York TimesJune 21, 2022
Five questions...
for Dr. Rulin Hechter
An infectious disease epidemiologist, Dr. Rulin Hechter focuses her research on substance abuse, disparities in health care utilization, and the prevention and treatment of HIV and other sexually transmitted infections. Read about her research and life in this Q&A.